Randomized, Single-Blind, Multicenter Phase II Study of Two Doses of Imetelstat in Relapsed or Refractory Myelofibrosis There is a need for industry-independent decision tools that integrate ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback